Home › Pulmonary Fibrosis › California
Pulmonary Fibrosis clinical trials in California
5 studies for Pulmonary Fibrosis are looking for participants at sites in California.
Cities in California
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Palmtree Clinical Research Inc., Palm Spring
- Paradigm Clinical Research Centers LLC, Redding
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07284602Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
- Stanford University, Stanford
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
- UCLA, Los Angeles
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT06162884Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
- Cedars-Sinai, Los Angeles
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Nov 10, 2025 · NCT06567717From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.